Detalhe da pesquisa
1.
Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer.
Nutr Cancer
; 74(1): 122-130, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438442
2.
Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease.
Digestion
; 102(4): 654-662, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841939
3.
A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial).
Neuroendocrinology
; 110(11-12): 988-993, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31986515
4.
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial.
BMC Cancer
; 19(1): 954, 2019 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615466
5.
Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD).
Jpn J Clin Oncol
; 49(3): 287-290, 2019 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30590606
6.
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
Br J Cancer
; 119(1): 19-26, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808014
7.
Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective study.
Jpn J Clin Oncol
; 47(12): 1151-1156, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977459
8.
Unexpected Side Effects of a High S-1 Dose: Subanalysis of a Phase III Trial Comparing Gemcitabine, S-1 and Combinatorial Treatments for Advanced Pancreatic Cancer.
Oncology
; 91(3): 117-26, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27303788
9.
Duodenal stenting followed by systemic chemotherapy for patients with pancreatic cancer and gastric outlet obstruction.
Pancreatology
; 16(6): 1085-1091, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27424479
10.
Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects.
BMC Gastroenterol
; 16(1): 83, 2016 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27473058
11.
Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study.
Cancer Sci
; 106(7): 883-90, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25867139
12.
Potential prognostic significance of a new proteomic profile in patients with advanced pancreatic adenocarcinoma.
Pancreatology
; 15(5): 525-530, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26255025
13.
Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis.
Hepatol Res
; 45(3): 279-87, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24802232
14.
Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial.
Jpn J Clin Oncol
; 45(5): 439-48, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25647781
15.
Enhancement of radiofrequency ablation of the liver combined with transarterial embolization using various embolic agents.
Abdom Imaging
; 40(6): 1821-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25526685
16.
Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.
Cancer Sci
; 105(10): 1321-6, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117729
17.
Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma.
Cancer Sci
; 105(4): 455-62, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24521523
18.
Renal toxicity associated with weekly cisplatin and gemcitabine combination therapy for treatment of advanced biliary tract cancer.
Oncology
; 87(1): 30-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24969038
19.
Therapeutic Outcome of Multidisciplinary Treatment in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Analysis.
World J Oncol
; 15(3): 405-413, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751699
20.
Inflammation in background cirrhosis evokes malignant progression in HCC development from HCV-associated liver cirrhosis.
Scand J Gastroenterol
; 48(6): 729-35, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23556482